Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosisStephanie Herman, Kim Kultima, Payam Emami Khoonsari et al.|Theranostics|2018Cited by 67
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple SclerosisStephanie Herman, Kim Kultima, Torbjörn Åkerfeldt et al.|Cells|2019Cited by 66
Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS—evaluation of whole blood, plasma, and serum as sample matricesHenrik Carlsson, Kim Kultima, Karin Hjorton et al.|Arthritis Research & Therapy|2020Cited by 50
Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometryHenrik Carlsson, Kim Kultima, Joachim Burman et al.|Metabolomics|2020Cited by 34
Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worseningAina Vaivade, Kim Kultima, Ida Erngren et al.|Nature Communications|2025Cited by 22